The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Mylan NV

Nasdaq: MYL
Last

(U.S.) $72.89

Today's change-0.16 -0.22%
Updated May 5 4:15 PM EDT. Delayed by at least 15 minutes.
 

Mylan NV

Nasdaq: MYL
Last

(U.S.) $72.89

Today's change-0.16 -0.22%
Updated May 5 4:15 PM EDT. Delayed by at least 15 minutes.

Mylan NV down (U.S.)$0.16

Mylan NV closed lower Tuesday, dropping (U.S.)$0.16 or 0.22% to (U.S.)$72.89. Over the last five days, shares are unchanged, but are currently 4.95% below its 52-week high. This security has outperformed the S&P 500 by 35.23% during the last year.

Key company metrics

  • Open(U.S.) $73.23
  • Previous close(U.S.) $73.05
  • High(U.S.) $73.76
  • Low(U.S.) $72.32
  • Bid / Ask(U.S.) $72.35 / (U.S.) $72.60
  • YTD % change+29.31%
  • Volume5,783,642
  • Average volume (10-day)11,474,212
  • Average volume (1-month)15,149,964
  • Average volume (3-month)8,533,976
  • 52-week range(U.S.) $44.80 to (U.S.) $76.69
  • Beta1.19
  • Trailing P/E31.21×
  • P/E 1 year forward17.57×
  • Forward PEG1.29×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.34
Updated May 5 4:15 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.09%

Based on its net profit margin of 12.09%, Mylan NV is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.26%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue2,0832,0841,8371,716
Total other revenue--------
Total revenue2,0832,0841,8371,716
Gross profit9821,024819748
Total cost of revenue1,1011,0601,019968
Total operating expense1,6971,5931,6121,480
Selling / general / administrative349379356335
Research & development150157139117
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)98779760
Other operating expenses, total0-80----
Operating income385491226236
Interest income (expense), net non-operating-50-92-93-91
Gain (loss) on sale of assets--------
Other--------
Income before tax272413138152
Income after tax191499127117
Income tax, total82-871135
Net income189499125116
Total adjustments to net income--------
Net income before extra. items189499125116
Minority interest-10-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items189499125116
Inc. avail. to common incl. extra. items189499125116
Diluted net income189499125116
Dilution adjustment0------
Diluted weighted average shares401397397397
Diluted EPS excluding extraordinary itemsvalue per share0.471.260.320.29
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.641.380.540.41